SEC Comment Letter 0000000000-24-007170 to TRINITY BIOTECH PLC (TRIB)
TRINITY BIOTECH PLC
Date: June 25, 2024 · CIK: 0000888721 · Accession: 0000000000-24-007170
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280391
Letter
United States securities and exchange commission logo June 25, 2024 John Gillard Chief Executive Officer Trinity Biotech plc IDA Business Park Bray, County Wicklow A98 H5C8 Ireland Re:Trinity Biotech plc Registration Statement on Form F-3 Filed June 21, 2024 File No. 333-280391 Dear John Gillard: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Mary Brown, Esq.
Show Raw Text
United States securities and exchange commission logo
June 25, 2024
John Gillard
Chief Executive Officer
Trinity Biotech plc
IDA Business Park
Bray, County Wicklow
A98 H5C8
Ireland
Re:Trinity Biotech plc
Registration Statement on Form F-3
Filed June 21, 2024
File No. 333-280391
Dear John Gillard:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Mary Brown, Esq.